Alteogen Poised for Surge in Milestone Revenue as Keytruda Qlex and Biosimilars Gain Momentum
Alteogen is set to accelerate its financial growth this year, driven by a surge in milestone payments and royalty revenues following a...
Search results for "pharmaceutical sales"
Samsung Bioepis Set to Launch Eylea Biosimilar in the U.S. Next January
Samsung Bioepis announced on the 12th that it has entered into a patent license agreement with the original developer regarding its low-dose (2mg)...
Launch of 'TrumpRX' Sells Drugs at Steep Discounts: Will Celltrion and Samsung Biologics Face Price Pressure?
The prescription drug sales platform 'TrumpRX', named after U. S. President Donald Trump, has officially launched.
Samsung Bioepis Aflibercept Biosimilar Available for Sale in Europe
Samsung Bioepis announced on the 30th that it has signed a patent agreement and licensing contract with the original...
Samsung Bioepis Achieves Record Sales of 1.672 Trillion Won Last Year
Samsung Bioepis achieved its highest performance last year in terms of sales. Excluding short-term milestone revenues,...
K-Toxins Heading to China... Will Hugel Be Followed After 5 Years in the Top 3?
Domestic botulinum toxin companies are racing towards the Chinese market. With Hugel, which entered China first,...
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
Samsung Bioepis to Directly Sell Ophthalmic Drug Baivubiz in Europe
Samsung Bioepis announced on the 4th that it has recovered the European commercialization rights for the ophthalmic...